DR. ALEXANDER EDWARD GLICK M.D. NPI 1598081911

NPI Details

DR. Alexander Edward Glick, M.D. is a medical oncology internal medicine in Sarasota, FL with 16 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Alexander Edward Glick, M.D. NPI is 1598081911. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1970 GOLF ST
SARASOTA, FL
ZIP 34236-908
Phone: (941) 957-1000
Fax: (941) 951-2117

The NPI 1598081911 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, mepolizumab, 1 mg (HCPCS:J2182)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, omalizumab, 5 mg (HCPCS:J2357)
• Injection, durvalumab, 10 mg (HCPCS:J9173)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Iron binding capacity (HCPCS:83550)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Folic acid level, serum (HCPCS:82746)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
• Protein measurement, serum (HCPCS:84165)
• Red blood count, automated test (HCPCS:85045)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Red blood count, manual test (HCPCS:85044)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Magnesium level (HCPCS:83735)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Drawing of blood for a medical problem (HCPCS:99195)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Blood test, clotting time (HCPCS:85610)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Automated urinalysis test (HCPCS:81003)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Uric acid level, blood (HCPCS:84550)
• Phosphate level (HCPCS:84100)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Vitamin d-3 level (HCPCS:82306)
• Erythropoietin (protein) level (HCPCS:82668)

The enumeration date for this NPI number is 4/9/2010 and was last updated on 12/1/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.